Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Mohr

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|February 5, 2021
From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in HepatocarcinogenesisRaphael Mohr, Burcin Özdirik, Joeri Lambrecht, et al.
Journal of Hepatocellular Carcinoma|June 17, 2026
Lobar Yttrium-90 Radioembolization with BSA-Based Dosimetry for Unresectable Hepatocellular Carcinoma: Baseline Vascularity Predicts Responders to the Combination with Targeted Therapy or Immune Checkpoint InhibitionWillie M Lüdemann, Johannes Kahn, Paul Herzler, et al.
Journal of the Mechanical Behavior of Biomedical Materials|June 1, 2026
Impact of severe hepatic iron overload on MR and ultrasound time-harmonic elastographySteffen P Häseli, Jakob Schattenfroh, Tom Meyer, et al.
Cells|January 24, 2025
miR-223 and Chromogranin A Affect Inflammatory Immune Cell Activation in Liver Metastasis of Neuroendocrine NeoplasmsLukas Geisler, Katharina Detjen, Teresa Hellberg, et al.
International Journal of Molecular Sciences|August 27, 2021
The Role of miRNA in the Pathophysiology of Neuroendocrine TumorsLukas Geisler, Raphael Mohr, Joeri Lambrecht, et al.
Plos One|December 31, 2020
Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumorsTeresa Hellberg, Raphael Mohr, Lukas Geisler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 28, 2019
Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIV-infected patientsMichael Praktiknjo, Natalie Djayadi, Raphael Mohr, et al.
Frontiers in Medicine|January 23, 2024
Optimized protocol for quantification of extracellular nicotinamide adenine dinucleotide: evaluating clinical parameters and pre-analytical factors for translational researchAl-Hussein Ahmed Saqr, Can Kamali, Philipp Brunnbauer, et al.
BMC Cancer|May 22, 2023
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC)Linde Kehmann, Marie-Luise Berres, Maria Gonzalez-Carmona, et al.
Cancers|November 9, 2024
Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular CarcinomaMara Egerer, Kathrin Schuch, David Schöler, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|February 5, 2021
From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in HepatocarcinogenesisRaphael Mohr, Burcin Özdirik, Joeri Lambrecht, et al.
Journal of Hepatocellular Carcinoma|June 17, 2026
Lobar Yttrium-90 Radioembolization with BSA-Based Dosimetry for Unresectable Hepatocellular Carcinoma: Baseline Vascularity Predicts Responders to the Combination with Targeted Therapy or Immune Checkpoint InhibitionWillie M Lüdemann, Johannes Kahn, Paul Herzler, et al.
Journal of the Mechanical Behavior of Biomedical Materials|June 1, 2026
Impact of severe hepatic iron overload on MR and ultrasound time-harmonic elastographySteffen P Häseli, Jakob Schattenfroh, Tom Meyer, et al.
Cells|January 24, 2025
miR-223 and Chromogranin A Affect Inflammatory Immune Cell Activation in Liver Metastasis of Neuroendocrine NeoplasmsLukas Geisler, Katharina Detjen, Teresa Hellberg, et al.
International Journal of Molecular Sciences|August 27, 2021
The Role of miRNA in the Pathophysiology of Neuroendocrine TumorsLukas Geisler, Raphael Mohr, Joeri Lambrecht, et al.
Plos One|December 31, 2020
Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumorsTeresa Hellberg, Raphael Mohr, Lukas Geisler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 28, 2019
Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIV-infected patientsMichael Praktiknjo, Natalie Djayadi, Raphael Mohr, et al.
Frontiers in Medicine|January 23, 2024
Optimized protocol for quantification of extracellular nicotinamide adenine dinucleotide: evaluating clinical parameters and pre-analytical factors for translational researchAl-Hussein Ahmed Saqr, Can Kamali, Philipp Brunnbauer, et al.
BMC Cancer|May 22, 2023
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC)Linde Kehmann, Marie-Luise Berres, Maria Gonzalez-Carmona, et al.
Cancers|November 9, 2024
Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular CarcinomaMara Egerer, Kathrin Schuch, David Schöler, et al.
Pageof 8